*To be consumed as directed by physician.
Therapies:
Anti Neoplastics
Composition:
Sunitinib Malate 12.5 mg
Mitant 12.5 mg Capsules contains Sunitinib Malate 12.5 mg, an anti-cancer medicine belonging to the group of tyrosine kinase inhibitors (TKIs). It is used in the treatment of kidney cancer and gastrointestinal stromal tumour (GIST). Sunitinib works by blocking specific proteins involved in the growth of cancer cells and the development of new blood vessels that supply tumors. This helps slow tumor growth and disease progression. It should be used only under the supervision of a healthcare professional experienced in cancer treatment.
*To be consumed as directed by physician.